In addition, genome-wide transcriptional profiling has demonstrated that the combined treatment of MCF7 breast cancer-derived cells with the chemotherapeutic agent doxorubicin and the inflammatory cytokine TNF-α results in the synergistic induction of ETV7 [20]. Here, ETV7 is linked to breast carcinoma.